Small-molecule theranostic probes: A promising future in neurodegenerative diseases

International Journal of Cell Biology

Volumn , Issue , 2013, Pages

  Aulić, Suzana ^a   Bolognesi, Maria Laura ^b   Legname, Giuseppe ^a  

^a SISSA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; AMPHOTERICIN B; ANTHRACYCLINE; AZO DYE; CONGO RED; MEMANTINE; MEPACRINE; PENTOSAN POLYSULFATE; PHENANTHRIDINE DERIVATIVE; PHTHALOCYANINE; POLYAMINE; PORPHYRIN; STILBENE; STILBENE DERIVATIVE; THIOFLAVINE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DIFFUSION WEIGHTED IMAGING; ELECTROENCEPHALOGRAM; FAMILIAL CREUTZFELDT JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; IATROGENIC CREUTZFELDT JAKOB DISEASE; IMMUNOASSAY; KURU; MOLECULAR PROBE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRION DISEASE; PRIORITY JOURNAL; REVIEW; VARIANT CREUTZFELDT JAKOB DISEASE; WESTERN BLOTTING;

ANIMALIA; BOVINAE;

EID: 84890052132     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2013/150952     Document Type: Review

References (182)

1. Rowe C. C., Ackerman U., Browne W., Mulligan R., Pike K. L., O'Keefe G., Tochon-Danguy H., Chan G., Berlangieri S. U., Jones G., Dickinson-Rowe K. L., Kung H. P., Zhang W., Kung M. P., Skovronsky D., Dyrks T., Holl G., Krause S., Friebe M., Lehman L., Lindemann S., Dinkelborg L. M., Masters C. L., Villemagne V. L., Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. The Lancet Neurology 2008 7 2 129 135 2-s2.0-38149081191 10.1016/S1474-4422(08)70001-2
2. O'keefe G. J., Saunder T. H., Ng S., Radiation dosimetry of beta-amyloid tracers 11c-Pib and 18f-bay94-9172. Journal of Nuclear Medicine 50 309 315
3. Koole M., Lewis D. M., Buckley C., Nelissen N., Vandenbulcke M., Brooks D. J., Vandenberghe R., Van Laere K., Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. Journal of Nuclear Medicine 2009 50 5 818 822 2-s2.0-66149104129 10.2967/jnumed.108. 060756
4. Fernandez-Fernandez A., Manchanda R., McGoron A. J., Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Applied Biochemistry and Biotechnology 2011 165 7-8 1628 1651 2-s2.0-81955167935 10.1007/s12010-011-9383-z
5. Lobatto M. E., Fuster V., Fayad Z. A., Mulder W. J. M., Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nature Reviews Drug Discovery 2011 10 11 835 852 2-s2.0-80255129385 10.1038/nrd3578
6. Ramos-Cabrer P., Campos F., Sobrino T., Castillo J., Targeting the ischemic penumbra. Stroke 2011 42 1 S7 S11 2-s2.0-79952117075 10.1161/STROKEAHA.110.596684
7. Staderini M., Aulić S., Bartolini M., A fluorescent styrylquinoline with combined therapeutic and diagnostic activities against Alzheimer's and Prion diseases. ACS Medicinal Chemistry Letters 2013 4 225 229
8. Prusiner S. B., Molecular biology of prion diseases. Science 1991 252 5012 1515 1522 2-s2.0-0025910229 (Pubitemid 21917065)
9. Jarrett J. T., Lansbury P. T. Jr., Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993 73 6 1055 1058 2-s2.0-0027195933 10.1016/0092-8674(93)90635-4 (Pubitemid 23180480)
10. Young G. S., Geschwind M. D., Fischbein N. J., Martindale J. L., Henry R. G., Liu S., Lu Y., Wong S., Liu H., Miller B. L., Dillon W. P., Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. American Journal of Neuroradiology 2005 26 6 1551 1562 2-s2.0-32944463783 (Pubitemid 43733460)
11. Xiao X., Cali I., Dong Z., Protease-sensitive prions with 144-bp insertion mutations. Aging 2013 5 155 173
12. Klunk W. E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D. P., Bergström M., Savitcheva I., Huang G.-F., Estrada S., Ausén B., Debnath M. L., Barletta J., Price J. C., Sandell J., Lopresti B. J., Wall A., Koivisto P., Antoni G., Mathis C. A., Långström B., Imaging brain amyloid in Alzheimer's disease with pittsburgh compound-B. Annals of Neurology 2004 55 3 306 319 2-s2.0-10744232413 10.1002/ana.20009 (Pubitemid 38269583)
13. Griffith J. S., Nature of the scrapie agent: self-replication and scrapie. Nature 1967 215 5105 1043 1044 2-s2.0-0014190760 10.1038/2151043a0
14. Prusiner S. B., Novel proteinaceous infectious particles cause scrapie. Science 1982 216 4542 136 144 2-s2.0-0020321767 (Pubitemid 12089840)
15. Creutzfeldt H. G., Über eine eigenartige herdförmige erkrankung des zentralnervensystems. Zeitschrift für die Gesamte Neurologie und Psychiatrie 1920 57 1 1 18 2-s2.0-33746127253 10.1007/BF02866081
16. Jakob A., Über eigenartige erkrankungen des zentralnervensystems mit bemerkenswertem anatomischen befunde (Spastische pseudosklerose- encephalomyclopathie mit disseminirrten degenerationsherden.). Zeitschrift für die Gesamte Neurologie und Psychiatrie 1921 64 1 147 228 2-s2.0-51849177198 10.1007/BF02870932
17. Kretzschmar H. A., Human prion diseases (spongiform encephalopathies). Archives of Virology. Supplementum 1993 7 261 293 2-s2.0-0027342789
18. Collinge J., Prion diseases of humans and animals: their causes and molecular basis. Annual Review of Neuroscience 2001 24 519 550 2-s2.0-0034916581 10.1146/annurev.neuro.24.1.519 (Pubitemid 32695238)
19. Collinge J., Palmer M. S., Dryden A. J., Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. The Lancet 1991 337 8755 1441 1442 2-s2.0-0025859996 10.1016/0140-6736(91)93128-V
20. Palmer M. S., Dryden A. J., Hughes J. T., Collinge J., Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991 352 6333 340 342 2-s2.0-0025820942 10.1038/352340a0 (Pubitemid 21912354)
21. Lee H. S., Sambuughin N., Cervenakova L., Chapman J., Pocchiari M., Litvak S., Qi H. Y., Budka H., Del Ser T., Furukawa H., Brown P., Gajdusek D. C., Long J. C., Korczyn A. D., Goldfarb L. G., Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. The American Journal of Human Genetics 1999 64 4 1063 1070 2-s2.0-0342505312 10.1086/302340 (Pubitemid 30463037)
22. Bertoni J. M., Brown P., Goldfarb L. G., Rubenstein R., Gajdusek D. C., Familial Creutzfeldt-Jakob disease (codon 200 mutation) with supranuclear palsy. Journal of the American Medical Association 1992 268 17 2413 2415 2-s2.0-0026662717 10.1001/jama.268.17.2413
23. Goldfarb L. G., Mitrova E., Brown P., Toh B. H., Gajdusek D. C., Mutation of codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. The Lancet 1990 336 8713 514 515 2-s2.0-0024995430 (Pubitemid 20264273)
24. Goldgaber D., Goldfarb L. G., Brown P., Asher D. M., Brown W. T., Lin S., Teener J. W., Feinstone S. M., Rubenstein R., Kascsak R. J., Boellaard J. W., Gajdusek D. C., Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker's syndrome. Experimental Neurology 1989 106 2 204 206 2-s2.0-0024467653 (Pubitemid 19279487)
25. Goldfarb L. G., Brown P., Haltia M., Cathala F., McCombie W. R., Kovanen J., Cervenakova L., Goldin L., Nieto A., Godec M. S., Asher D. M., Gajdusek D. C., Creutzfeldt-Jakob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin. Annals of Neurology 1992 31 3 274 281 2-s2.0-0026552106
26. Haltia M., Kovanen J., Goldfarb L. G., Brown P., Gajdusek D. C., Familial Creutzfeldt-Jakob disease in Finland: epidemiological, clinical, pathological and molecular genetic studies. European Journal of Epidemiology 1991 7 5 494 500 2-s2.0-0026044686
27. Nieto A., Goldfarb L. G., Brown P., McCombie W. R., Trapp S., Asher D. M., Gajdusek D. C., Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. The Lancet 1991 337 8741 622 623 2-s2.0-0026082629
28. Mastrianni J. A., Capellari S., Telling G. C., Han D., Bosque P., Prusiner S. B., DeArmond S. J., Inherited prion disease caused by the V210I mutation: transmission to transgenic mice. Neurology 2001 57 12 2198 2205 2-s2.0-0035956518 (Pubitemid 34016451)
29. Duffy P., Wolf J., Collins G., DeVoe A. G., Streeten B., Cowen D., Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. The New England Journal of Medicine 1974 290 12 692 693 2-s2.0-0016398968
30. Brown P., Brandel J. P., Sato T., Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerging Infectious Diseases 2012 18 901 907
31. Will R. G., Ironside J. W., Zeidler M., Cousens S. N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofmar A., Smith P. G., A new variant of Creutzfeldt-Jakob disease in the UK. The Lancet 1996 347 9006 921 925 2-s2.0-0342951746 10.1016/S0140-6736(96)91412-9
32. Cousens S. N., Vynnycky E., Zeidier M., Will R. G., Smith P. G., Predicting the CDJ epidemic in humans. Nature 1997 385 6613 197 198 2-s2.0-0031574612 10.1038/385197a0 (Pubitemid 27045728)
33. Ghani A. C., Ferguson N. M., Donnelly C. A., Hagenaars T. J., Anderson R. M., Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. Proceedings of the Royal Society B 1998 265 1413 2443 2452 2-s2.0-0032558983 10.1098/rspb.1998.0596 (Pubitemid 29015453)
34. Scott M. R., Will R., Ironside J., Nguyen H.-O. B., Tremblay P., DeArmond S. J., Prusiner S. B., Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proceedings of the National Academy of Sciences of the United States of America 1999 96 26 15137 15142 2-s2.0-0033592877 10.1073/pnas.96.26.15137 (Pubitemid 30019778)
35. Will R. G., The transmission of prions to humans. Acta Paediatrica 1999 88 433 28 32 2-s2.0-0033431702 (Pubitemid 30007329)
36. Collinge J., New diagnostic tests for prion diseases. The New England Journal of Medicine 1996 335 13 963 965 2-s2.0-0029810684 10.1056/ NEJM199609263351310 (Pubitemid 26314452)
37. Collinge J., Sidle K. C. L., Meads J., Ironside J., Hill A. F., Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996 383 6602 685 690 2-s2.0-0029831213 10.1038/383685a0 (Pubitemid 26360638)
38. Peden A. H., Head M. W., Ritchie D. L., Bell P. J. E., Ironside P. J. W., Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. The Lancet 2004 364 9433 527 529 2-s2.0-4043157677 10.1016/S0140- 6736(04)16811-6 (Pubitemid 39070413)
39. Cervenáková L., Goldfarb L. G., Garruto R., Lee H.-S., Gajdusek D. C., Brown P., Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proceedings of the National Academy of Sciences of the United States of America 1998 95 22 13239 13241 2-s2.0-0032573211 10.1073/pnas.95.22.13239 (Pubitemid 28509555)
40. Windl O., Dempster M., Estibeiro J. P., Lathe R., De Silva R., Esmonde T., Will R., Springbett A., Campbell T. A., Sidle K. C. L., Palmer M. S., Collinge J., Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Human Genetics 1996 98 3 259 264 2-s2.0-2442735162 10.1007/s004390050204 (Pubitemid 26258371)
41. Baker H. F., Poulter M., Cros T. J., Frith C. D., Lofthouse R., Ridley R. M., Collinge J., Aminoacid polymorphism in human prion protein and age at death in inherited prion disease. The Lancet 1991 337 8752 1286 2-s2.0-0025865455
42. Hsiao K., Dlouhy S. R., Farlow M. R., Cass C., Da Costa M., Conneally P. M., Hodes M. E., Ghetti B., Prusiner S. B., Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nature Genetics 1992 1 1 68 71 2-s2.0-0026849947
43. Ghetti B., Dlouhy S. R., Giaccone G., Gerstmann-Straussler-Scheinker disease and the Indiana kindred. Brain Pathology 1995 5 61 75 10.1111/j.1750-3639.1995.tb00578.x
44. Masters C. L., Gajdusek D. C., Gibbs C. J. Jr., Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 1981 104 559 588 (Pubitemid 12202196)
45. Gerstmann J., Sträussler E., Scheinker I., Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems. Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Zeitschrift für die Gesamte Neurologie und Psychiatrie 1936 154 736 762
46. Hsiao K., Baker H. F., Crow T. J., Poulter M., Owen F., Terwilliger J. D., Westaway D., Ott J., Prusiner S. B., Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 1989 338 6213 342 345 2-s2.0-0024519771 (Pubitemid 19082975)
47. Yamada M., Itoh Y., Fujigasaki H., Naruse S., Kaneko K., Kitamoto T., Tateishi J., Otomo E., Hayakawa M., Tanaka J., Matsushita M., Miyatake T., A missense mutation at codon 105 with codon 129 polymorphism of the prion protein gene in a new variant of Gerstmann-Straussler-Scheinker disease. Neurology 1993 43 12 I 2723 2724 2-s2.0-0027729337 (Pubitemid 24004583)
48. Doh-ura K., Tateishi J., Sasaki H., Kitamoto T., Sakaki Y., Pro→Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Straussler syndrome. Biochemical and Biophysical Research Communications 1989 163 2 974 979 2-s2.0-0024473899 (Pubitemid 19236945)
49. Panegyres P. K., Toufexis K., Kakulas B. A., Cernevakova L., Brown P., Ghetti B., Piccardo P., Dlouhy S. R., A new PRNP mutation (G131V) associated with Gerstmann-Sträussler-Scheinker disease. Archives of Neurology 2001 58 11 1899 1902 2-s2.0-0034766589 (Pubitemid 33044260)
50. Dlouhy S. R., Hsiao K., Farlow M. R., Foroud T., Conneally P. M., Johnson P., Prusiner S. B., Hodes M. E., Ghetti B., Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene. Nature Genetics 1992 1 1 64 67 2-s2.0-0026849545
51. Helmus J. J., Surewicz K., Nadaud P. S., Surewicz W. K., Jaroniec C. P., Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proceedings of the National Academy of Sciences of the United States of America 2008 105 17 6284 6289 2-s2.0-44049102092 10.1073/pnas.0711716105 (Pubitemid 351758338)
52. Helmus J. J., Surewicz K., Surewicz W. K., Jaroniec C. P., Conformational flexibility of Y145stop human prion protein amyloid fibrils probed by solid-state nuclear magnetic resonance spectroscopy. Journal of the American Chemical Society 2010 132 7 2393 2403 2-s2.0-77749237271 10.1021/ja909827v
53. Jansen C., Parchi P., Capellari S., Vermeij A. J., Corrado P., Baas F., Strammiello R., Van Gool W. A., Van Swieten J. C., Rozemuller A. J. M., Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathologica 2010 119 2 189 197 2-s2.0-77449089995 10.1007/s00401-009-0609-x
54. Kovács G. G., Trabattoni G., Hainfellner J. A., Ironside J. W., Knight R. S. G., Budka H., Mutations of the prion protein gene: phenotypic spectrum. Journal of Neurology 2002 249 11 1567 1582 2-s2.0-0036459944 10.1007/s00415-002-0896-9 (Pubitemid 35477900)
55. Jansen C., Voet W., Head M. W., Parchi P., Yull H., Verrips A., Wesseling P., Meulstee J., Baas F., Van Gool W. A., Ironside J. W., Rozemuller A. J. M., A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann-Sträussler-Scheinker disease phenotype: comparison with similar cases from the literature. Acta Neuropathologica 2011 121 1 59 68 2-s2.0-78651248344 10.1007/s00401-010-0656-3
56. Lugaresi E., Medori R., Montagna P., Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. The New England Journal of Medicine 1986 315 16 997 1003 2-s2.0-0022447484 (Pubitemid 16028581)
57. Almer G., Hainfellner J. A., Brücke T., Jellinger K., Kleinert R., Bayer G., Windl O., Kretzschmar H. A., Hill A., Sidle K., Collinge J., Budka H., Fatal familial insomnia: a new Austrian family. Brain 1999 122 1 5 16 2-s2.0-0032905278 10.1093/brain/122.1.5 (Pubitemid 29046268)
58. Carota A., Pizzolato G. P., Gailloud P., Macchi G., Fasel J., Le Floch J., Cardone F., A panencephalopathic type of Creutzfeldt-Jakob disease with selective lesions of the thalamic nuclei in 2 Swiss patients. Clinical Neuropathology 1996 15 3 125 134 2-s2.0-0029989832 (Pubitemid 26164822)
59. Padovani A., D'Alessandro M., Parchi P., Cortelli P., Anzola G. P., Montagna P., Vignolo L. A., Petraroli R., Pocchiari M., Lugaresi E., Gambetti P., Fatal familial insomnia in a new Italian kindred. Neurology 1998 51 5 1491 1494 2-s2.0-0031798080 (Pubitemid 28520591)
60. McLean C. A., Storey E., Gardner R. J. M., Tannenberg A. E. G., Cervenáková L., Brown P., The D178N (cis-129M) 'fatal familial insomnia' mutation associated with diverse clinicopathologic phenotypes in an Australian kindred. Neurology 1997 49 2 552 558 2-s2.0-0030821246
61. Nagayama M., Shinohara Y., Furukawa H., Kitamoto T., Fatal familial insomnia with a mutation at codon 178 of the priori protein gene: first report from Japan. Neurology 1996 47 5 1313 1316 2-s2.0-0029961971 (Pubitemid 26374905)
62. Medori R., Tritschler H.-J., LeBlanc A., Villare F., Manetto V., Hsiao Ying Chen H. Y. C., Xue R., Leal S., Montagna P., Cortelli P., Tinuper P., Avoni P., Mochi M., Baruzzi A., Hauw J. J., Ott J., Lugaresi E., Autilio-Gambetti L., Gambetti P., Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. The New England Journal of Medicine 1992 326 7 444 449 2-s2.0-0026552043
63. Mastrianni J. A., Nixon R., Layzer R., Telling G. C., Han D., DeArmond S. J., Prusiner S. B., Prion protein conformation in a patient with sporadic fatal insomnia. The New England Journal of Medicine 1999 340 21 1630 1638 2-s2.0-0033609313 10.1056/NEJM199905273402104 (Pubitemid 29249432)
64. Scaravilli F., Cordery R. J., Kretzschmar H., Sporadic fatal insomnia: a case study. Annals of Neurology 2000 48 665 668
65. Parchi P., Capellari S., Chin S., Schwarz H. B., Schecter N. P., Butts J. D., Hudkins P., Burns O. K., Powers J. M., Gambetti P., A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology 1999 52 9 1757 1763 2-s2.0-0032976574 (Pubitemid 29260886)
66. Montagna P., Gambetti P., Cortelli P., Lugaresi E., Familial and sporadic fatal insomnia. The Lancet Neurology 2003 2 3 167 176 2-s2.0-0041851001 10.1016/S1474-4422(03)00323-5 (Pubitemid 37443320)
67. Gajdusek D. C., Zigas V., Degenerative disease of the central nervous system in New Guinea, the endemic occurrence of kuru in the native population. The New England Journal of Medicine 1957 257 20 974 978 2-s2.0-78651041685
68. Westergard L., Christensen H. M., Harris D. A., The cellular prion protein (PrPC): its physiological function and role in disease. Biochimica et Biophysica Acta 2007 1772 6 629 644 2-s2.0-34249936265 10.1016/j.bbadis.2007.02. 011 (Pubitemid 46880208)
69. Nazor K. E., Seward T., Telling G. C., Motor behavioral and neuropathological deficits in mice deficient for normal prion protein expression. Biochimica et Biophysica Acta 2007 1772 6 645 653 2-s2.0-34249947609 10.1016/j.bbadis.2007.04.004 (Pubitemid 46880209)
70. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.-P., DeArmond S. J., Prusiner S. B., Aguet M., Weissmann C., Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992 356 6370 577 582 2-s2.0-0026600865 10.1038/356577a0
71. Manson J. C., Clarke A. R., Hooper M. L., Aitchison L., McConnell I., Hope J., 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Molecular Neurobiology 1994 8 2-3 121 127 2-s2.0-0028420937 10.1007/BF02780662
72. Bueler H., Aguzzi A., Sailer A., Greiner R.-A., Autenried P., Aguet M., Weissmann C., Mice devoid of PrP are resistant to scrapie. Cell 1993 73 7 1339 1347 2-s2.0-0027319326 10.1016/0092-8674(93)90360-3 (Pubitemid 23201147)
73. Fournier J.-G., Escaig-Haye F., de Villemeur T. B., Robain O., Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus. Comptes Rendus de l'Academie des Sciences 1995 318 3 339 344 2-s2.0-0029112533
74. Moya K. L., Sales N., Hassig R., Immunolocalization of the cellular prion protein in normal brain. Microscopy Research and Technique 2000 50 58 65 10.1002/1097-0029(20000701)50:1<58::AID-JEMT9>3.0.CO;2-5 (Pubitemid 30497406)
75. Salès N., Rodolfo K., Hässig R., Faucheux B., Di Giamberardino L., Moya K. L., Cellular prion protein localization in rodent and primate brain. European Journal of Neuroscience 1998 10 7 2464 2471 2-s2.0-0031866162 10.1046/j.1460-9568.1998.00258.x (Pubitemid 28302347)
76. Sanchez-Juan P., Green A., Ladogana A., Cuadrado-Corrales N., Sáanchez-Valle R., Mitrováa E., Stoeck K., Sklaviadis T., Kulczycki J., Hess K., Bodemer M., Slivarichováa D., Saiz A., Calero M., Ingrosso L., Knight R., Janssens A. C. J. W., van Duijn C. M., Zerr I., CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006 67 4 637 643 2-s2.0-33747689817 10.1212/01.wnl.0000230159.67128.00 (Pubitemid 44273611)
77. Zerr I., Kallenberg K., Summers D. M., Romero C., Taratuto A., Heinemann U., Breithaupt M., Varges D., Meissner B., Ladogana A., Schuur M., Haik S., Collins S. J., Jansen G. H., Stokin G. B., Pimentel J., Hewer E., Collie D., Smith P., Roberts H., Brandel J. P., Van Duijn C., Pocchiari M., Begue C., Cras P., Will R. G., Sanchez-Juan P., Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009 132 4 2659 2668 2-s2.0-84860156130 10.1093/brain/ awp191
78. Zeidler M., Stewart G. E., Barraclough C. R., Bateman D. E., Bates D., Burn D. J., Colchester A. C., Durward W., Fletcher N. A., Hawkins S. A., Mackenzie J. M., Will R. G., New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. The Lancet 1997 350 9082 903 907 2-s2.0-0031588178 10.1016/S0140-6736(97)07472-2 (Pubitemid 27420525)
79. Johnson R. T., Gibbs C. J. Jr., Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. The New England Journal of Medicine 1998 339 27 1994 2004 2-s2.0-0032585594 10.1056/NEJM199812313392707 (Pubitemid 29024133)
80. Hsiao K. K., Groth D., Scott M., Yang S.-L., Serban H., Rapp D., Foster D., Torchia M., DeArmond S. J., Prusiner S. B., Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proceedings of the National Academy of Sciences of the United States of America 1994 91 19 9126 9130 2-s2.0-0028608963 10.1073/pnas.91.19.9126
81. Telling G. C., Scott M., Hsiao K. K., Foster D., Yang S.-L., Torchia M., Sidle K. C. L., Collinge J., Dearmond S. J., Prusiner S. B., Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proceedings of the National Academy of Sciences of the United States of America 1994 91 21 9936 9940 2-s2.0-0028102794 10.1073/pnas.91.21.9936 (Pubitemid 24311923)
82. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F. E., Prusiner S. B., Eight prion strains have PrP(Sc) molecules with different conformations. Nature Medicine 1998 4 10 1157 1165 2-s2.0-0031720905 10.1038/2654 (Pubitemid 28468829)
83. Gambetti P., Dong Z., Yuan J., Xiao X., Zheng M., Alshekhlee A., Castellani R., Cohen M., Barria M. A., Gonzalez-Romero D., Belay E. D., Schonberger L. B., Marder K., Harris C., Burke J. R., Montine T., Wisniewski T., Dickson D. W., Soto C., Hulette C. M., Mastrianni J. A., Kong Q., Zou W.-Q., A novel human disease with abnormal prion protein sensitive to protease. Annals of Neurology 2008 63 6 697 708 2-s2.0-46749121818 10.1002/ana.21420 (Pubitemid 351945529)
84. Colby D. W., Wain R., Baskakov I. V., Legname G., Palmer C. G., Nguyen H.-O. B., Lemus A., Cohen F. E., DeArmond S. J., Prusiner S. B., Protease-sensitive synthetic prions. PLoS Pathogens 2010 6 1 2-s2.0-77649214076 10.1371/journal.ppat.1000736 e1000736
85. Safar J. G., Scott M., Monaghan J., Deering C., Didorenko S., Vergara J., Ball H., Legname G., Leclerc E., Solforosi L., Serban H., Groth D., Burton D. R., Prusiner S. B., Williamson R. A., Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nature Biotechnology 2002 20 11 1147 1150 2-s2.0-0036843448 10.1038/nbt748 (Pubitemid 35285445)
86. Lee I. S., Long J. R., Prusiner S. B., Safar J. G., Selective precipitation of prions by polyoxometalate complexes. Journal of the American Chemical Society 2005 127 40 13802 13803 2-s2.0-26444434251 10.1021/ja055219y (Pubitemid 41437025)
87. Saborio G. P., Permanne B., Soto C., Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001 411 6839 810 813 2-s2.0-0035859102 10.1038/35081095 (Pubitemid 32588105)
88. Saá P., Castilla J., Soto C., Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. The Journal of Biological Chemistry 2006 281 46 35245 35252 2-s2.0-33845944898 10.1074/jbc.M603964200 (Pubitemid 46036562)
89. Gough K. C., Baker C. A., Rees H. C., Terry L. A., Spiropoulos J., Thorne L., Maddison B. C., The oral secretion of infectious scrapie prions occurs in preclinical sheep with a range of PRNP genotypes. Journal of Virology 2012 86 1 566 571 2-s2.0-84855936004 10.1128/JVI.05579-11
90. Terry L. A., Howells L., Bishop K., Baker C. A., Everest S., Thorne L., Maddison B. C., Gough K. C., Detection of prions in the faeces of sheep naturally infected with classical scrapie. Veterinary Research 2011 42 1, article 65 2-s2.0-80052009162 10.1186/1297-9716-42-65
91. Maddison B. C., Raes H. C., Baker C. A., Taema M., Bellworthy S. J., Thorne L., Terry L. A., Gough K. C., Prions are secreted into the oral cavity in sheep with preclinical scrapie. Journal of Infectious Diseases 2010 201 11 1672 1676 2-s2.0-77951904692 10.1086/652457
92. Maddison B. C., Baker C. A., Rees H. C., Terry L. A., Thorne L., Bellworthy S. J., Whitelam G. C., Gough K. C., Prions are secreted in milk from clinically normal scrapie-exposed sheep. Journal of Virology 2009 83 16 8293 8296 2-s2.0-67749104664 10.1128/JVI.00051-09
93. Thorne L., Terry L. A., In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. Journal of General Virology 2008 89 12 3177 3184 2-s2.0-58149380989 10.1099/vir.0.2008/004226-0
94. Legname G., Baskakov I. V., Nguyen H.-O. B., Riesner D., Cohen F. E., DeArmond S. J., Prusiner S. B., Synthetic mammalian prions. Science 2004 305 5684 673 676 2-s2.0-3442889359 10.1126/science.1100195 (Pubitemid 39006757)
95. Colby D. W., Zhang Q., Wang S., Groth D., Legname G., Riesner D., Prusiner S. B., Prion detection by an amyloid seeding assay. Proceedings of the National Academy of Sciences of the United States of America 2007 104 52 20914 20919 2-s2.0-38049170554 10.1073/pnas.0710152105
96. Orrú C. D., Wilham J. M., Raymond L. D., Kuhn F., Schroeder B., Raeber A. J., Caughey B., Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. mBio 2011 2 3 e00078 e00011 2-s2.0-79960163849 10.1128/mBio.00078-11
97. Atarashi R., Wilham J. M., Christensen L., Hughson A. G., Moore R. A., Johnson L. M., Onwubiko H. A., Priola S. A. S. A., Caughey B., Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nature Methods 2008 5 3 211 212 2-s2.0-40149090017 10.1038/nmeth0308-211 (Pubitemid 351325633)
98. Orrú C. D., Wilham J. M., Hughson A. G., Raymond L. D., McNally K. L., Bossers A., Ligios C., Caughey B., Human variant Creutzfeldt-Jakob disease and sheep scrapie PrPres detection using seeded conversion of recombinant prion protein. Protein Engineering, Design and Selection 2009 22 8 515 521 2-s2.0-70349211719 10.1093/protein/gzp031
99. Atarashi R., Satoh K., Sano K., Fuse T., Yamaguchi N., Ishibashi D., Matsubara T., Nakagaki T., Yamanaka H., Shirabe S., Yamada M., Mizusawa H., Kitamoto T., Klug G., McGlade A., Collins S. J., Nishida N., Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nature Medicine 2011 17 2 175 178 2-s2.0-79751535822 10.1038/nm.2294
100. Wilham J. M., Orrú C. D., Bessen R. A., Atarashi R., Sano K., Race B., Meade-White K. D., Taubner L. M., Timmes A., Caughey B., Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathogens 2010 6 12 2-s2.0-78651249792 10.1371/journal.ppat.1001217 e1001217
101. Gmitterová K., Heinemann U., Bodemer M., Krasnianski A., Meissner B., Kretzschmar H. A., Zerr I., 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiology of Aging 2009 30 11 1842 1850 2-s2.0-70049114839 10.1016/j.neurobiolaging.2008.01.007
102. Haïk S., Brandel J. P., Salomon D., Sazdovitch V., Delasnerie-Lauprêtre N., Laplanche J. L., Faucheux B. A., Soubrié C., Boher E., Belorgey C., Hauw J. J., Alpérovitch A., Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects. Neurology 2004 63 12 2413 2415 2-s2.0-19944375077
103. Whittle I. R., Knight R. S. G., Will R. G., Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease. Acta Neurochirurgica 2006 148 6 677 678 2-s2.0-33745113535 10.1007/s00701-006-0772-y (Pubitemid 43881796)
104. Gilbert I. H., Rudyk H., Inhibitors of protease-resistant prion formation. International Antiviral News 1999 7 5 78 82 2-s2.0-0032816362 (Pubitemid 29374066)
105. Koster T., Singh K., Zimmermann M., Gruys E., Emerging therapeutic agents for transmissible spongiform encephalopathies: a review. Journal of Veterinary Pharmacology and Therapeutics 2003 26 5 315 326 2-s2.0-0242551778 10.1046/j.1365-2885.2003.00525.x (Pubitemid 37378507)
106. Pankiewicz J., Prelli F., Sy M.-S., Kascsak R. J., Kascsak R. B., Spinner D. S., Carp R. I., Meeker H. C., Sadowski M., Wisniewski T., Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. European Journal of Neuroscience 2006 23 10 2635 2647 2-s2.0-33744478405 10.1111/j.1460-9568.2006.04805.x (Pubitemid 43801455)
107. Supattapone S., Nishina K., Rees J. R., Pharmacological approaches to prion research. Biochemical Pharmacology 2002 63 8 1383 1388 2-s2.0-0037091006 10.1016/S0006-2952(02)00874-2 (Pubitemid 34457952)
108. Farquhar C., Dickinson A., Bruce M., Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies. The Lancet 1999 353 9147 117 2-s2.0-0033537348 10.1016/S0140-6736(98)05395-1
109. Caughey B., Ernst D., Race R. E., Congo red inhibition of scrapie agent replication. Journal of Virology 1993 67 10 6270 6272 2-s2.0-0027280172 (Pubitemid 23277541)
110. Demaimay R., Adjou K. T., Beringue V., Demart S., Lasmézas C. I., Deslys J.-P., Seman M., Dormont D., Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. Journal of Virology 1997 71 12 9685 9689 2-s2.0-0030778819 (Pubitemid 27492417)
111. Tagliavini F., McArthur R. A., Canciani B., Giaccone G., Porro M., Bugiani M., Lievens P. M.-J., Bugiani O., Peri E., Dall'Ara P., Rocchi M., Poli G., Forloni G., Bandiera T., Varasi M., Suarato A., Cassutti P., Cervini M. A., Lansen J., Salmona M., Post C., Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 1997 276 5315 1119 1122 2-s2.0-17344382240 10.1126/science.276.5315.1119 (Pubitemid 27218121)
112. Caughey W. S., Raymond L. D., Horiuchi M., Caughey B., Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proceedings of the National Academy of Sciences of the United States of America 1998 95 21 12117 12122 2-s2.0-0032514682 10.1073/pnas.95.21.12117 (Pubitemid 28483728)
113. Bach S., Talarek N., Andrieu T., Vierfond J.-M., Mettey Y., Galons H., Dormont D., Meijer L., Cullin C., Blondel M., Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nature Biotechnology 2003 21 9 1075 1081 2-s2.0-10744225913 10.1038/nbt855 (Pubitemid 37064738)
114. Müller W. E. G., Laplanche J.-L., Ushijima H., Schröder H. C., Novel approaches in diagnosis and therapy of Creutzfeldt-Jakob disease. Mechanisms of Ageing and Development 2000 116 2-3 193 218 2-s2.0-0342409474 10.1016/S0047-6374(00)00112-3
115. Doh-Ura K., Iwaki T., Caughey B., Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie- associated prion protein accumulation. Journal of Virology 2000 74 10 4894 4897 2-s2.0-0034001444 10.1128/JVI.74.10. 4894-4897.2000 (Pubitemid 30237920)
116. Korth C., May B. C. H., Cohen F. E., Prusiner S. B., Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proceedings of the National Academy of Sciences of the United States of America 2001 98 17 9836 9841 2-s2.0-0035859806 10.1073/pnas.161274798 (Pubitemid 32769390)
117. May B. C. H., Fafarman A. T., Hong S. B., Rogers M., Deady L. W., Prusiner S. B., Cohen F. E., Potent inhibition of scrapie prion replication in cultured cells by bis-acridines. Proceedings of the National Academy of Sciences of the United States of America 2003 100 6 3416 3421 2-s2.0-0037452925 10.1073/pnas.2627988100 (Pubitemid 36356598)
118. Goñi F., Knudsen E., Schreiber F., Scholtzova H., Pankiewicz J., Carp R., Meeker H. C., Rubenstein R., Brown D. R., Sy M.-S., Chabalgoity J. A., Sigurdsson E. M., Wisniewski T., Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience 2005 133 2 413 421 2-s2.0-21144432949 10.1016/j.neuroscience.2005.02.031 (Pubitemid 40726209)
119. Sigurdsson E. M., Wisniewski T., Promising developments in prion immunotherapy. Expert Review of Vaccines 2005 4 5 607 610 2-s2.0-27444448236 10.1586/14760584.4.5.607 (Pubitemid 41530585)
120. Bertsch U., Winklhofer K. F., Hirschberger T., Bieschke J., Weber P., Hartl F. U., Tavan P., Tatzelt J., Kretzschmar H. A., Giese A., Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets. Journal of Virology 2005 79 12 7785 7791 2-s2.0-19944405458 10.1128/JVI.79.12.7785-7791.2005 (Pubitemid 40756812)
121. Kocisko D. A., Baron G. S., Rubenstein R., Chen J., Kuizon S., Caughey B., New inhibitors of scrapie-associated prion protein formation in a library of 2,000 drugs and natural products. Journal of Virology 2003 77 19 10288 10294 2-s2.0-0141632823 10.1128/JVI.77.19.10288-10294.2003 (Pubitemid 37129672)
122. Agdeppa E. D., Kepe V., Liu J., Flores-Torres S., Satyamurthy N., Petric A., Cole G. M., Small G. W., Huang S. C., Barrio J. R., Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. Journal of Neuroscience 2001 21 24 RC189 2-s2.0-0035893245
123. Zhuang Z.-P., Kung M.-P., Wilson A., Lee C.-W., Plössl K., Hou C., Holtzman D. M., Kung H. F., Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting β -amyloid plaques in the brain. Journal of Medicinal Chemistry 2003 46 2 237 243 2-s2.0-0037448350 10.1021/jm020351j (Pubitemid 36078143)
124. Bresjanac M., Smid L. M., Vovko T. D., Petrič A., Barrio J. R., Popovic M., Molecular-imaging probe 2-(1-{6-[(2-fluoroethyl)(methyl) amino]-2-naphthyl}ethylidene) malononitrile labels prion plaques in vitro. Journal of Neuroscience 2003 23 22 8029 8033 2-s2.0-0041335200 (Pubitemid 37082455)
125. Bacskai B. J., Klunk W. E., Mathis C. A., Hyman B. T., Imaging amyloid- β deposits in vivo. Journal of Cerebral Blood Flow and Metabolism 2002 22 9 1035 1041 2-s2.0-0036711817
126. Poduslo J. F., Wengenack T. M., Curran G. L., Wisniewski T., Sigurdsson E. M., Macura S. I., Borowski B. J., Jack C. R. Jr., Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiology of Disease 2002 11 2 315 329 2-s2.0-0036965918 10.1006/nbdi.2002. 0550 (Pubitemid 36135695)
127. Higuchi M., Iwata N., Matsuba Y., Sato K., Sasamoto K., Saido T. C., 19F and 1H MRI detection of amyloid β plaques in vivo. Nature Neuroscience 2005 8 4 527 533 2-s2.0-20044392910 10.1038/nn1422 (Pubitemid 41007572)
128. Shoghi-Jadid K., Small G. W., Agdeppa E. D., Kepe V., Ercoli L. M., Siddarth P., Read S., Satyamurthy N., Petric A., Huang S.-C., Barrio J. R., Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. American Journal of Geriatric Psychiatry 2002 10 1 24 35 2-s2.0-18244388509 10.1176/appi.ajgp.10.1.24 (Pubitemid 34052900)
129. Ono M., Wilson A., Nobrega J., Westaway D., Verhoeff P., Zhuang Z.-P., Kung M.-P., Kung H. F., 11C-labeled stilbene derivatives as A β -aggregate-specific PET imaging agents for Alzheimer's disease. Nuclear Medicine and Biology 2003 30 6 565 571 2-s2.0-0142075238 10.1016/S0969-8051(03)00049-0 (Pubitemid 37289318)
130. Engler H., Forsberg A., Almkvist O., Blomquist G., Larsson E., Savitcheva I., Wall A., Ringheim A., Långström B., Nordberg A., Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 2006 129 11 2856 2866 2-s2.0-33749506795 10.1093/brain/awl178 (Pubitemid 44684508)
131. Rowe C. C., Ng S., Ackermann U., Gong S. J., Pike K., Savage G., Cowie T. F., Dickinson K. L., Maruff P., Darby D., Smith C., Woodward M., Merory J., Tochon-Danguy H., O'Keefe G., Klunk W. E., Mathis C. A., Price J. C., Masters C. L., Villemagne V. L., Imaging β -amyloid burden in aging and dementia. Neurology 2007 68 20 1718 1725 2-s2.0-34248579291 10.1212/01.wnl.0000261919. 22630.ea (Pubitemid 46763260)
132. Hintersteiner M., Enz A., Frey P., Jaton A.-L., Kinzy W., Kneuer R., Neumann U., Rudin M., Staufenbiel M., Stoeckli M., Wiederhold K.-H., Gremlich H.-U., In vivo detection of amyloid- β deposits by near-infrared imaging using an oxazine-derivative probe. Nature Biotechnology 2005 23 5 577 583 2-s2.0-22144433066 10.1038/nbt1085 (Pubitemid 41724896)
133. Nesterov E. E., Skoch J., Hyman B. T., Klunk W. E., Bacskai B. J., Swager T. M., In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers. Angewandte Chemie 2005 44 34 5452 5456 2-s2.0-24644457702 10.1002/anie.200500845 (Pubitemid 41273293)
134. Choi S. R., Golding G., Zhuang Z., Zhang W., Lim N., Hefti F., Benedum T. E., Kilbourn M. R., Skovronskyhank D., Kung H. F., Preclinical properties of18F-AV-45: a PET agent for A β plaques in the brain. Journal of Nuclear Medicine 2009 50 11 1887 1894 2-s2.0-70350716476 10.2967/jnumed.109.065284
135. Wong D. F., Rosenberg P. B., Zhou Y., Kumar A., Raymont V., Ravert H. T., Dannals R. F., Nandi A., Brašić J. R., Ye W., Hilton J., Lyketsos C., Kung H. F., Joshi A. D., Skovronsky D. M., Pontecorvo M. J., In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand18F-AV-45 (flobetapir F 18). Journal of Nuclear Medicine 2010 51 6 913 920 2-s2.0-77953937194 10.2967/jnumed.109.069088
136. Westermark G. T., Johnson K. H., Westermark P., Staining methods for identification of amyloid in tissue. Methods in Enzymology 1999 309 3 25 2-s2.0-0032855076 10.1016/S0076-6879(99)09003-5 (Pubitemid 29446438)
137. Steensma D. P., "Congo" red: out of Africa? Archives of Pathology and Laboratory Medicine 2001 125 2 250 252 2-s2.0-0035257136
138. Klunk W. E., Pettegrew J. W., Abraham D. J., Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. Journal of Histochemistry and Cytochemistry 1989 37 8 1273 1281 2-s2.0-0024352110 (Pubitemid 19186029)
139. Klunk W. E., Debnath M. L., Pettegrew J. W., Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease. Neurobiology of Aging 1994 15 6 691 698 2-s2.0-0028076051 10.1016/0197-4580(94) 90050-7 (Pubitemid 24360159)
140. Cooper J. H., Selective amyloid staining as a function of amyloid composition and structure. Histochemical analysis of the alkaline Congo red, standardized toluidine blue, and iodine methods. Laboratory Investigation 1974 31 3 232 238 2-s2.0-0016287131
141. Frid P., Anisimov S. V., Popovic N., Congo red and protein aggregation in neurodegenerative diseases. Brain Research Reviews 2007 53 1 135 160 2-s2.0-33845192482 10.1016/j.brainresrev.2006.08.001 (Pubitemid 44854214)
142. Burgevin M.-C., Passat M., Daniel N., Capet M., Doble A., Congo red protects against toxicity of β -amyloid peptides on rat hippocampal neurones. NeuroReport 1994 5 18 2429 2432 2-s2.0-0028588694
143. Lorenzo A., Yankner B. A., β -Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proceedings of the National Academy of Sciences of the United States of America 1994 91 25 12243 12247 2-s2.0-0028172886 10.1073/pnas.91.25.12243 (Pubitemid 24368641)
144. Pollack S. J., Sulfonated dyes attenuate the toxic effects of β -amyloid in a structure-specific fashion. Neuroscience Letters 1995 197 3 211 214 2-s2.0-0029117593 10.1016/0304-3940(95)11939-T
145. Gellermann G. P., Ullrich K., Tannert A., Unger C., Habicht G., Sauter S. R. N., Hortschansky P., Horn U., Möllmann U., Decker M., Lehmann J., Fändrich M., Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin. Journal of Molecular Biology 2006 360 2 251 257 2-s2.0-33745235789 10.1016/j.jmb.2006.05.026 (Pubitemid 43927837)
146. Crowther D. C., Kinghorn K. J., Miranda E., Page R., Curry J. A., Duthie F. A. I., Gubb D. C., Lomas D. A., Intraneuronal A β non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 2005 132 1 123 135 2-s2.0-15044339964 10.1016/j.neuroscience.2004. 12.025 (Pubitemid 40380720)
147. Caughey B., Race R. E., Potent inhibition of scrapie-associated PrP accumulation by Congo red. Journal of Neurochemistry 1992 59 2 768 771 2-s2.0-0026638150 10.1111/j.1471-4159.1992.tb09437.x
148. Ingrosso L., Ladogana A., Pocchiari M., Congo red prolongs the incubation period in scrapie-infected hamsters. Journal of Virology 1995 69 1 506 508 2-s2.0-0028970386 (Pubitemid 24378829)
149. Poli G., Ponti W., Carcassola G., Ceciliani F., Colombo L., Dall'Ara P., Gervasoni M., Giannino M. L., Martino P. A., Pollera C., Villa S., Salmona M., In vitro evaluation of the anti-prionic activity of newly synthesized Congo red derivatives. Arzneimittel-Forschung 2003 53 12 875 888 2-s2.0-9144223018 (Pubitemid 38021438)
150. Fraser P. E., Nguyen J. T., Chin D. T., Kirschner D. A., Effects of sulfate ions on Alzheimer β /A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. Journal of Neurochemistry 1992 59 4 1531 1540 2-s2.0-0026673537
151. Rudyk H., Vasiljevic S., Hennion R. M., Birkett C. R., Hope J., Gilbert I. H., Screening Congo red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells. Journal of General Virology 2000 81 4 1155 1164 2-s2.0-0034109546 (Pubitemid 30189659)
152. Klunk W. E., Debnath M. L., Pettegrew J. W., Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe. Neurobiology of Aging 1995 16 4 541 548 2-s2.0-0029083059 10.1016/0197-4580(95)00058-M
153. Klunk W. E., Debnath M. L., Koros A. M. C., Pettegrew J. W., Chrysamine-G, a lipophilic analogue of Congo red, inhibits A β -induced toxicity in PC12 cells. Life Sciences 1998 63 20 1807 1814 2-s2.0-0032500717 10.1016/S0024-3205(98)00454-8 (Pubitemid 28511613)
154. Styren S. D., Hamilton R. L., Styren G. C., Klunk W. E., X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. Journal of Histochemistry and Cytochemistry 2000 48 9 1223 1232 2-s2.0-0033857342
155. Skovronsky D. M., Zhang B., Kung M.-P., Kung H. F., Trojanowski J. Q., Lee V. M.-Y., In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2000 97 13 7609 7614 2-s2.0-0034691124 10.1073/pnas.97.13.7609 (Pubitemid 30431511)
156. Ishikawa K., Doh-ura K., Kudo Y., Nishida N., Murakami-Kubo I., Ando Y., Sawada T., Iwaki T., Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies. Journal of General Virology 2004 85 6 1785 1790 2-s2.0-2942672633 10.1099/vir.0.19754-0 (Pubitemid 38807776)
157. Vassar P. S., Culling C. F., Fluorescent stains, with special reference to amyloid and connective tissues. Archives of Pathology 1959 68 487 498 2-s2.0-0000464103
158. Voropai E. S., Samtsov M. P., Kaplevskii K. N., Maskevich A. A., Stepuro V. I., Povarova O. I., Kuznetsova I. M., Turoverov K. K., Fink A. L., Uverskii V. N., Spectral properties of thioflavin T and its complexes with amyloid fibrils. Journal of Applied Spectroscopy 2003 70 6 868 874 2-s2.0-3543147687 10.1023/B:JAPS.0000016303.37573.7e
159. Naiki H., Higuchi K., Hosokawa M., Takeda T., Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Analytical Biochemistry 1989 177 2 244 249 2-s2.0-0024509805 (Pubitemid 19088253)
160. Naiki H., Higuchi K., Matsushima K., Shimada A., Chen W.-H., Hosokawa M., Takeda T., Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, Thioflavine T. Laboratory Investigation 1990 62 6 768 773 2-s2.0-0025440053 (Pubitemid 20213696)
161. Naiki H., Higuchi K., Nakakuki K., Takeda T., Kinetic analysis of amyloid fibril polymerization in vitro. Laboratory Investigation 1991 65 1 104 110 2-s2.0-0025826915
162. LeVine H. III, Thioflavine T interaction with synthetic Alzheimer's disease β -amyloid peptides: detection of amyloid aggregation in solution. Protein Science 1993 2 3 404 410 2-s2.0-0027502784
163. LeVine H. I., Thioflavine T interaction with amyloid beta-sheet structures. Amyloid 1995 2 1 1 6 10.3109/13506129509031881
164. Cai L., Innis R. B., Pike V. W., Radioligand development for PET imaging of β -amyloid (A β)-current status. Current Medicinal Chemistry 2007 14 1 19 52 2-s2.0-33846032313 10.2174/092986707779313471 (Pubitemid 46050302)
165. Klunk W. E., Wang Y., Huang G.-F., Debnath M. L., Holt D. P., Mathis C. A., Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sciences 2001 69 13 1471 1484 2-s2.0-0035902875 10.1016/S0024-3205(01)01232-2 (Pubitemid 32786721)
166. Mathis C. A., Bacskai B. J., Kajdasz S. T., McLellan M. E., Frosch M. P., Hyman B. T., Holt D. P., Wang Y., Huang G.-F., Debnath M. L., Klunk W. E., A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorganic and Medicinal Chemistry Letters 2002 12 3 295 298 2-s2.0-0037059914 10.1016/S0960-894X(01)00734-X (Pubitemid 34113887)
167. Hyare H., Ramlackhansingh A., Gelosa G., 11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery & Psychiatry 2012 83 340 341 10.1136/jnnp.2010.233692
168. Mathis C. A., Wang Y., Holt D. P., Huang G.-F., Debnath M. L., Klunk W. E., Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. Journal of Medicinal Chemistry 2003 46 13 2740 2754 2-s2.0-0038792263 10.1021/jm030026b (Pubitemid 36702542)
169. Kung H. F., Lee C.-W., Zhuang Z.-P., Kung M.-P., Hou C., Plössl K., Novel stilbenes as probes for amyloid plaques. Journal of the American Chemical Society 2001 123 50 12740 12741 2-s2.0-0035915387 10.1021/ja0167147 (Pubitemid 33140424)
170. Kung H. F., Kung M.-P., Zhuang Z. P., Hou C., Lee C.-W., Plössl K., Zhuang B., Skovronsky D. M., Lee V. M.-Y., Trojanowski J. Q., Iodinated tracers for imaging amyloid plaques in the brain. Molecular Imaging and Biology 2003 5 6 418 426 2-s2.0-0344983869 10.1016/j.mibio.2003.09.003 (Pubitemid 37489832)
171. Okamura N., Suemoto T., Shimadzu H., Suzuki M., Shiomitsu T., Akatsu H., Yamamoto T., Staufenbiel M., Yanai K., Arai H., Sasaki H., Kudo Y., Sawada T., Styrylbenzoxazole derivatives for in vivo imaging amyloid plaques in the brain. Journal of Neuroscience 2004 24 10 2535 2541 2-s2.0-12144289490 10.1523/JNEUROSCI.4456-03.2004 (Pubitemid 38327966)
172. Ishikawa K., Kudo Y., Nishida N., Suemoto T., Sawada T., Iwaki T., Doh-Ura K., Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopathies. Journal of Neurochemistry 2006 99 1 198 205 2-s2.0-33748685214 10.1111/j.1471-4159.2006. 04035.x (Pubitemid 44395142)
173. Zhang W., Oya S., Kung M.-P., Hou C., Maier D. L., Kung H. F., F-18 stilbenes as PET imaging agents for detecting β -amyloid plaques in the brain. Journal of Medicinal Chemistry 2005 48 19 5980 5988 2-s2.0-24944586305 10.1021/jm050166g (Pubitemid 41324608)
174. Ono M., Haratake M., Nakayama M., Kaneko Y., Kawabata K., Mori H., Kung M.-P., Kung H. F., Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease. Nuclear Medicine and Biology 2005 32 4 329 335 2-s2.0-18844406576 10.1016/j.nucmedbio.2005.01.006 (Pubitemid 40692683)
175. Li Q., Min J., Ahn Y.-H., Namm J., Kim E. M., Lui R., Kim H. Y., Ji Y., Wu H., Wisniewski T., Chang Y.-T., Styryl-based compounds as potential in vivo imaging agents for β -amyloid plaques. ChemBioChem 2007 8 14 1679 1687 2-s2.0-34948887647 10.1002/cbic.200700154 (Pubitemid 47523672)
176. Cavalli A., Bolognesi M. L., Capsoni S., Andrisano V., Bartolini M., Margotti E., Cattaneo A., Recanatini M., Melchiorre C., A small molecule targeting the multifactorial nature of Alzheimer's disease. Angewandte Chemie 2007 46 20 3689 3692 2-s2.0-34250872774 10.1002/anie.200700256 (Pubitemid 46981250)
177. Bongarzone S., Tran H. N. A., Cavalli A., Roberti M., Carloni P., Legname G., Bolognesi M. L., Parallel synthesis, evaluation, and preliminary structure-activity relationship of 2,5-diamino-1,4-benzoquinones as a novel class of bivalent anti-prion compound. Journal of Medicinal Chemistry 2010 53 22 8197 8201 2-s2.0-78649507705 10.1021/jm100882t
178. Kuwata K., Nishida N., Matsumoto T., Kamatari Y. O., Hosokawa-Muto J., Kodama K., Nakamura H. K., Kimura K., Kawasaki M., Takakura Y., Shirabe S., Takata J., Kataoka Y., Katamine S., Hot spots in prion protein for pathogenic conversion. Proceedings of the National Academy of Sciences of the United States of America 2007 104 29 11921 11926 2-s2.0-34547538273 10.1073/pnas.0702671104 (Pubitemid 47185606)
179. Raymond S. B., Kumar A. T. N., Boas D. A., Bacskai B. J., Optimal parameters for near infrared fluorescence imaging of amyloid plaques in Alzheimer's disease mouse models. Physics in Medicine and Biology 2009 54 20 6201 6216 2-s2.0-70449125861 10.1088/0031-9155/54/20/011
180. Chongzhao R., Xiaoyin X., Raymond S. B., Ferrara B. J., Neal K., Bacskai B. J., Medarova Z., Moore A., Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid- β deposits. Journal of the American Chemical Society 2009 131 42 15257 15261 2-s2.0-70350316758 10.1021/ja9047043
181. Schmidt A., Pahnke J., Efficient near-infrared in vivo imaging of amyoid-beta deposits in Alzheimer's disease mouse models. Journal of Alzheimer's Disease 2012 30 651 664
182. Raymond S. B., Skoch J., Hills I. D., Nesterov E. E., Swager T. M., Bacskai B. J., Smart optical probes for near-infrared fluorescence imaging of Alzheimer's disease pathology. European Journal of Nuclear Medicine and Molecular Imaging 2008 35 1 S93 S98 2-s2.0-41149139305 10.1007/s00259-007-0708-7